Coexistence of lipid disorders and arterial hypertension in the population of 50 year old subjects;Współwystȩpowanie zaburzeń lipidowych i nadciśnienia tȩtniczego w populacji osób w wieku 50 lat

Nadcisnienie Tetnicze

Volumn 8, Issue 2, 2004, Pages 97-102

  Gnacińska, Maria ^a   Zdrojewski, Tomasz ^a   Wierucki, Łukasz ^a   Kȩdzierski, Maciej ^a   Rutkowski, Marcin ^a   Bandosz, Piotr ^a   Szpakowski, Paweł ^a   Karpiński, Ryszard ^b   Szpajer, Michat ^c   Winiarska, Alina ^c   Wyrzykowski, Bogdan ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Urza̧d Miasta ^*  (Poland)

^c Urza d Miasta   (Poland)

Author keywords

Arterial hypertension; Hypercholesterolemia; Lipid disorders

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SCREENING; STROKE;

EID: 18244417257     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kaplan N., Weidmann P. Introduction: is hypertension a metabolic disease? American Heart Journal 1993; 125: 1485-1487.
2. Pearson T.A., Blair S.N., Daniels S.R. i wsp. AHA Guideliness for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patents without Coronary or other atherosclerotic vascular Disease. Circulation 2002; 106: 388-391.
3. Prevention of coronary heart disease in clinical practise. Recommendation of the Second Joint Task Force of the European and other societies on Coronary Prevention. Prepared by D. Wood, G. de Backer, O. Faergeman, I. Graham, G. Mancia, K. Pyöräla, Eur. Heart. J. 1998; 19: 1434-1509.
4. Zasady postȩpowania w nadciśnieniu tȩtniczym. Stanowisko Polskiego Towarzystwa Nadciśnienia Tȩtniczego. Nadciśnienie Tȩtnicze 2000; 4, supl B: B1-B34.
5. Prewencja, wykrywanie, diagnostyka i leczenie nadciśnienia tȩtniczego. Siódmy raport Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7). Medycyna Praktyczna 2003; 6: 23-64.
6. Krotkiewski M., Björntorp P., Sjöström L., Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 1983; 72: 1150-1162.
7. Huang Z., Willet W., Manson J., Rosner B., Stampfer M. i wsp. Body weight, weight change, and risk for hypertension in women. Ann. Intern. Med. 1998; 128: 81-88.
8. www.stat.gov.pl/publikacje/demogr/stanu_zdrowia_lu.htm
9. Wykrywanie, ocena i leczenie hipercholesterolemii u doroslych. III Raport Ekspertów National Cholesterol Education Program (USA). Medycyna praktyczna, wydanie specjalne 2003; 4.
10. Hausmann D., Mügge A., Daniel W. Koronare Herzkrankheit; 1096-1100. M. Flasnoecker (red.). Thiemes Innere Medizin: TIM. Georg Thieme Verlag, Stuttgart 1999.
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
12. Creager M.A., Gallagher S.J., Girerd X.J., Coleman S.M. i wsp. Arginine improvs endothelium-dependend vasodilatation in hypercholesterolemic humans. J. Clin. Invest. 1992; 90: 1248-1253.
13. Libby P. Molecular basis of the acute coronary syndrome. Circulation 1995; 91: 2844-2850.
14. Prasa K., Kara J. Oxygen free radicals and hypercholesterolemic atherosclerosis effect of vitamin E. American Heart Journal 1993; 125: 858-973.
15. Kaplan N.M. Obesity in hypertension: effects on prognosis and treatment. J. Hypertens 1998; (supl. 1) 16: S35-S37.
16. Rywik S. Zaburzenia metaboliczne u chorych z nadciśnieniem tȩtniczym - badanie populacyjne. Czynniki Ryzyka 2002; 2-3: 38-43.
17. Broda D., Szcześniewska D., Rywik S. Czȩstość wystȩpowania zespołu metabolicznego w populacji osób dorosłych Warszawy. Medycyna Metaboliczna 2003; 7: 25-29.
18. Lorenzo C., Serrano-Rios M., Martinez-Larrad M. i wsp. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 2002; 39: 203-208.
19. Reckelhoff J. Gender differences in the regulation of blood pressure. Hypertension 2001; 37: 1199-1208.
20. Ely D., Turner M. Hypertension in the spontaneously hypertension rate is linked to the Y chromosome. Hypertension 1990; 16: 277-281.
21. Ellis J., Stebbing M., Harrap S. Association of the human Y chromosome with high blood pressure in the general population. Hypertension 2000; 36: 731-733.
22. Charchar F.J., Dominiczak A. i wsp. The Y chromosome effect on blood pressure in two European population. Hypertension 2002; 39: 353-356.
23. Kren V., Qi N., Krenova D., Zidek V., Sla M. Y-Chromosome transfer induces changes in blood pressure and blood lipids in SHR. Hypertension 2001; 37: 1147-1152.
24. Dantas Ana Paula V., Tostes Rita C.A., Fortes Zuleica B., Costa Sonia G., Nigro D., Corvallro Maria Helena C. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002; 39: 405-411.
25. Unger T. The role of renin-angiotensin system in the development of cardiovascular disease. Am. J. Card. 2002; 89, Nr 2A: 3A-10A.
26. Lind L., Lithell H., Wide L., Ljunghall S. Metabolic cardiovascular risk factors and the renin-aldosteron system in essential hypertension. Journal Human Hypertension 1992; 6: 27-29.